Jiangsu Hengrui | 600276 - Ebitda

Stock Price
56.51
Daily Change
0.92 1.66%
Monthly
-2.59%
Yearly
21.53%
Q1 Forecast
53.88

Jiangsu Hengrui reported CNY2.98B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 5.71B 1.36B Jun/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025